Read Natalies Story Who Can Benefit Individuals who are overweight or obese and have struggled to lose weight through diet and exercise Patients with pre-diabetes, insulin resistance or type 2 diabetes Those experiencing weight-related conditions, such as high blood pressure, elevated cholesterol, fatty liver disease, cardiovascular disease and sleep apnea Individuals seeking a physician-guided, holistic weight-loss plan GLP-1 therapy may not be suitable for everyone, including individuals with certain thyroid, pancreatic or gastrointestinal conditions
Data synthesis The studies varied in terms intervention type, dosage regimens, duration of treatment, study design, and participant characteristics such as disease stage and concurrent medication hence given the substantial heterogeneity, a quantitative meta-analysis was not performed
Use cautiously in autoimmune disorders or those using immunosuppressants, as Astaxanthin has been shown to enhance immune function and theoretically could interfere with immunosuppressive therapy such as Rofecoxib
Development of a new thiol site-specific prosthetic group and its conjugation with [Cys(40)]-exendin-4 for in vivo targeting of insulinomas
